Welcome to our dedicated page for Baxter Intl news (Ticker: BAX), a resource for investors and traders seeking the latest updates and insights on Baxter Intl stock.
Baxter International Inc. (NYSE: BAX) is a global medtech company whose news flow reflects its focus on connected care technologies, medical devices and advanced injectable therapies. On this page, readers can follow company announcements that illustrate how Baxter’s products and partnerships intersect with hospital operations, nursing workflows and patient safety.
Recent Baxter news highlights the launch of the Dynamo Series smart stretcher, designed for emergency departments, perioperative environments and patient transport services. Baxter reports that the Dynamo Series is intended to reduce the need for patient transfers, support a range of procedures in-stretcher, and incorporate technologies such as SafeView+ visual cues, bed exit alarms and optional connectivity to EMRs and nurse call systems to help prevent patient falls and support care teams.
Other updates include a multi-year strategic partnership with MUSC Health focused on integrating connected care technologies at the bedside. Baxter and MUSC Health describe objectives such as standardizing and simplifying bedside technologies, reducing documentation time, streamlining communication, improving nurse satisfaction and retention, and using real-time insights and advanced monitoring to enhance quality and safety outcomes.
Baxter also issues news on its infusion therapy portfolio, such as real-world data presented with The University of Texas Medical Branch on the Spectrum IQ large volume infusion pumps. These analyses examine how smart pump integration with electronic medical records may affect patient safety alerts, infusion programming time and clinician workload.
In addition, investors can find announcements on capital allocation decisions, including tender offers for senior notes, new note issuances and dividend declarations, as well as philanthropic news from the Baxter Foundation, such as grants to support STEM education through the Baxter Center for Science Education. Bookmark this page to access Baxter’s latest product, partnership, financial and community impact news in one place.
Baxter International Inc. (NYSE:BAX) will hold a conference call on February 9, 2023, at 7:30 a.m. Central Time to discuss its fourth-quarter 2022 financial results. Interested participants can pre-register through the provided link or access the call via Baxter’s website. The call will also be recorded for future reference. Baxter continues to be a leader in healthcare with a diverse portfolio including critical care, kidney care, and surgical products utilized globally. For more insights, visit www.baxter.com.
Baxter International Inc. (NYSE:BAX) has announced plans to spin off its Renal Care and Acute Therapies units into a publicly traded company within 12-18 months. This restructuring aims to simplify operations, enhance strategic focus, and improve long-term performance. Additionally, Baxter will explore strategic alternatives for its BioPharma Solutions business to optimize its capital structure. The proposed changes are designed to strengthen Baxter's market position and foster innovation, with sales for the renal unit in 2021 reaching $5 billion.
Summary not available.
The ExactaMix Pro Automated Compounder from Baxter International (NYSE:BAX), set for release in early 2023, enhances security and user experience while offering superior data reporting capabilities. It will be showcased at the ASHP Midyear Clinical Meeting from Dec. 4-8, 2022. This advanced system is certified to the FDA-recognized UL 2900-2-1 cybersecurity standard and provides features designed for increased efficiency and ease of use, including touchscreen responsiveness and 15 months of data storage. ExactaMix Pro signals a significant advancement in compounding technology.
Baxter International Inc. (NYSE:BAX) will participate in the 5th Annual Evercore ISI HealthCONx Conference on December 1, 2022, at 1:00 p.m. Eastern Time. Chief Financial Officer Jay Saccaro will present at the event. A live webcast will be available on www.baxter.com and can be replayed until May 30, 2023. With a legacy of 90 years, Baxter continues to innovate in areas like diagnostic and critical care solutions across over 100 countries, helping millions of patients and caregivers globally.
Baxter International Inc. (NYSE:BAX) has declared a quarterly cash dividend of $0.29 per share, payable on January 3, 2023. Shareholders of record by December 2, 2022 will receive this dividend. The annual dividend rate is set at $1.16 per share. Baxter continues to maintain its commitment to returning value to shareholders while focusing on innovations in healthcare.
Baxter International Inc. (NYSE:BAX) presented significant data at Kidney Week 2022 demonstrating the benefits of its remote patient management platform, Sharesource, and the Theranova dialyzer. A controlled study revealed that Sharesource improves outcomes for home peritoneal dialysis patients by reducing adverse events. Additionally, ex vivo studies indicated that Theranova effectively removes larger middle-molecule toxins while maintaining albumin stability during hemodialysis. These innovations aim to enhance patient care in response to the global kidney disease crisis.
Baxter International reported third-quarter 2022 revenue of $3.8 billion, a 17% increase on a reported basis. U.S. GAAP EPS was ($5.83), reflecting $3.1 billion in impairment charges from the Hillrom acquisition, attributed to rising interest rates and equity declines. Adjusted EPS was $0.82, a 20% decrease year-over-year. International sales grew 1%, while U.S. sales surged 40%. Despite challenges from supply constraints and competition, Baxter's product innovations continue to drive growth. The company anticipates 17%-18% sales growth for the full year.
Baxter International Inc. (NYSE:BAX) will host a conference call on October 27, 2022, at 7:30 a.m. Central Time to discuss its third-quarter financial results. Interested participants can pre-register for the call via the provided link. The call will also be webcasted through Baxter’s official website, where it will be accessible after the live session. Baxter provides critical healthcare products across multiple sectors, serving patients globally. For more information, visit www.baxter.com.
Baxter International Inc. (NYSE:BAX) has announced a commitment of